GI Insights

GI Insights

ReachMD
Country USA
Language EN
Episodes 323
Latest 02.11.2026

GI Insights provides updates on screening guidelines, diagnostic options, and management tools for diseases and disorders affecting the gastrointestinal tract. The podcast covers the latest in gastroenterology, including new research and clinical practices. It is produced by ReachMD, a medical education platform.

Episodes

  • Treating Obesity Today: GLP-1s, Surgery, and Beyond
    Treating Obesity Today: GLP-1s, Surgery, and Beyond 02.11.2026 10m
    Guest: Devika Umashanker, MD Today, obesity treatment often combines medical and surgical strategies rather than following a strict step-by-step approach. GLP-1 therapies, older medications, and procedures like sleeve gastrectomy and gastric bypass all have a place in an individualized, patient-centered plan. Joining Dr. Peter Buch to discuss how we can integrate these approaches into obesity care is Dr. Devika Umashanker, Program Director of the Obesity Medicine Fellowship at Hartford HealthCare and an Associate Professor of Internal Medicine at the Frank H. Netter MD School of Medicine at Qu...
  • Managing MASLD in Patients with Obesity
    Managing MASLD in Patients with Obesity 02.11.2026 7m
    Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David Tendler, MD Obesity is one of the biggest drivers of metabolic dysfunction-associated steatotic liver disease (MASLD), and the two conditions often need to be managed together. To get patients the results they need, clinicians must know how to screen effectively, rule out other liver conditions, and match treatment to disease stage. On this episode of GI Insights, Dr. Peter Buch talks with Dr. David Tendler about how to approach these decisions in everyday practice. Dr. Tendler is part of the clinical faculty at the Duke University Department...
  • Staying Ahead of IBD Complications
    Staying Ahead of IBD Complications 16.10.2026 12m
    Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Harish Gagneja, MD Inflammatory bowel disease (IBD) care has shifted from managing symptoms to preventing the long-term consequences of inflammation that a patient may not feel. In this episode of GI Insights, Dr. Peter Buch speaks with Dr. Harish Gagneja about proactive IBD management, from monitoring disease control between colonoscopies and tailoring colorectal cancer surveillance to preventing postoperative Crohn’s recurrence and VTE in hospitalized patients. Dr. Gagneja is a board-certified gastroenterologist in Austin, Texas.
  • Gastric Cancer Prevention: A Risk-Based Approach
    Gastric Cancer Prevention: A Risk-Based Approach 18.08.2026 14m
    Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Chul Hyun, MD, PhD, MPH Gastric cancer risk in the United States varies substantially across populations, yet prevention remains largely based on symptoms. Join Dr. Peter Buch and Dr. Chul Hyun, Director of the Gastric Cancer Prevention and Screening Program at the Yale School of Medicine, as they explore how recognizing key risk factors may help us identify patients who warrant closer evaluation.
  • Managing Early Esophageal and Gastric Cancers: ASGE Recommendations on ESD and EMR
    Managing Early Esophageal and Gastric Cancers: ASGE Recommendations on ESD and EMR 29.05.2026 12m
    Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Vivek Kaul, MD The American Society for Gastrointestinal Endoscopy (ASGE) recently released a new guideline on when to use endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) in managing early esophageal and gastric cancers. To learn more about when to use each approach, Dr. Peter Buch sits down with guideline co-author Dr. Vivek Kaul. Dr. Kaul is also the Segal-Watson Professor of Medicine at the University of Rochester Medical Center in New York.
  • Screening Modalities for Colon Cancer: What You Need to Know
    Screening Modalities for Colon Cancer: What You Need to Know 29.05.2026 11m
    Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Aasma Shaukat, MD, MPH While fecal immunochemical testing and multitarget stool DNA testing are commonly used to screen for colon cancer, screening rates remain low throughout the United States. With the introduction of blood-based testing modalities, noninvasive colon cancer screening is becoming more accessible than ever. Join host Dr. Peter Buch and Dr. Aasma Shaukat as they discuss the effectiveness of current and emerging methods as well as best practices for screening patients. Dr. Shaukat is the Robert M. and Mary H. Glickman Professor of Me...
  • Assessing Racial Disparities in Colorectal Cancer Screening
    Assessing Racial Disparities in Colorectal Cancer Screening 30.04.2026 14m
    Host: Neilanjan Nandi, MD Guest: Folasade P. May, MD, PhD, MPhil Racial and ethnic bias prevent patients with colorectal cancer from receiving the highest quality of care. Dr. Neil Nandi is joined by Dr. Fola May, Assistant Professor of Medicine at UCLA, to discuss racial inequalities in access to care and screening for patients with colorectal cancer.
  • Recapping the 2021 ACG Clinical Guidelines: What’s New in Colorectal Cancer Screening?
    Recapping the 2021 ACG Clinical Guidelines: What’s New in Colorectal Cancer Screening? 30.04.2026 13m
    Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Aasma Shaukat, MD, MPH Screening for colorectal cancer is unique because there are several screening options available. So how can we balance the latest ACG Clinical Guidelines with patient preferences, cultural context, and insurance coverage to find the best screening option for our patients? Joining Dr. Peter Buch to discuss the updated recommendations is Dr. Aasma Shaukat, lead author of the 2021 ACG Clinical Guidelines for colorectal cancer screening.
  • Strategies for Increasing Colorectal Cancer Screening Rates
    Strategies for Increasing Colorectal Cancer Screening Rates 30.04.2026 9m
    Host: Neilanjan Nandi, MD Guest: Samir Shah, MD From new guideline recommendations to a concert featuring the American College of Gastroenterology’s official band, a lot is being done to help raise awareness of the importance of screening for colorectal cancer. So how can you help increase screening rates in your own community? Get inspired with these creative initiatives shared by Dr. Neil Nandi and Dr. Samir Shah, President of the American College of Gastroenterology.
  • Adenoma Detection Rate: A Prediction of Colorectal Cancer
    Adenoma Detection Rate: A Prediction of Colorectal Cancer 30.04.2026 13m
    Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Aasma Shaukat, MD, MPH Adenoma detection rate (ADR) may help us better detect our patients’ risk of developing colorectal cancer. To explore what we need to know about this quality indicator, Dr. Peter Buch joins Dr. Aasma Shaukat from the New York University Grossman School of Medicine to talk about ADR.
  • Colorectal Cancer in Young Patients: A Multidisciplinary Approach
    Colorectal Cancer in Young Patients: A Multidisciplinary Approach 30.04.2026 12m
    Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David Liska, MD Since the 1990s, clinicians have been seeing a significant increase in colorectal cancer among young patients, who are under the age of 50. A multidisciplinary approach is key as diagnostic and treatment considerations are specific to their age. Dive in with Dr. Peter Buch as he’s joined by Dr. David Liska, Section Chief of Oncology in the Department of Colorectal Surgery at the Cleveland Clinic.
  • Developments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing
    Developments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing 30.04.2026 10m
    Host: Peter Buch, MD, FACG, AGAF, FACP Guest: William Grady, MD While colorectal cancer is the second most common cause of cancer deaths, only a third of people between the ages of 45 and 75 are compliant with screening recommendations. However, cell-free DNA blood-based tests could become a new option for colorectal cancer screening. Dr. Peter Buch sits down with GI expert Dr. William Grady to discuss the efficacy of this new test and where it is in the FDA approval process.
  • Making the Right Choices for Patients with Ulcerative Colitis
    Making the Right Choices for Patients with Ulcerative Colitis 22.01.2026 14m
    Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David P. Hudesman, MD Ulcerative colitis treatment continues to evolve with a growing range of targeted therapies, from S1P modulators to JAK inhibitors. Joining Dr. Peter Buch to discuss how clinicians can personalize care based on disease severity, safety profiles, and patient response is Dr. David Hudesman. He's a Professor in the Department of Medicine at NYU Grossman School of Medicine and the Director of NYU Langone’s Inflammatory Bowel Disease Center.
  • Advances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests
    Advances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests 24.11.2025 13m
    Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Aasma Shaukat, MD, MPH Blood-based colorectal cancer screening is entering a new era with FDA-approved and emerging tests like Shield and Simple Screen. Alongside updated stool-based options such as Cologuard Plus and CRC-PREVENT, clinicians now have a broader landscape of noninvasive tools to consider and discuss with their patients. Joining Dr. Peter Buch to talk about current recommendations and potential future directions for colorectal cancer screening is Dr. Aasma Shaukat. Dr. Shaukat is the Robert M. and Mary H. Glickman Professor of Medicin...
  • Diagnosing and Treating Hemochromatosis: Expert Insights
    Diagnosing and Treating Hemochromatosis: Expert Insights 28.10.2025 13m
    Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Paul Adams, MD Hemochromatosis, a genetic condition that causes the body to absorb too much iron from food, often goes unrecognized despite its prevalance. With unique diagnostic and management challenges, it's crucial to understand how it presents, which testing strategies are most effective, and what treatment options are available. Tune in to hear Dr. Peter Buch and Dr. Paul Adams, Professor in the Division of Gastroenterology at the Western University in London, Canada, discuss the latest on hemochromatosis.
  • AI in GI: Leveraging CADe to Improve Colonoscopy Performance and Accuracy
    AI in GI: Leveraging CADe to Improve Colonoscopy Performance and Accuracy 03.10.2025 12m
    Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Charles Kahi, MD Computer-aided detection systems (CADe) are transforming adenoma detection and enhancing colonoscopy quality. Dr. Peter Buch sits down with Dr. Charles Kahi to unpack the latest American Gastroenterological Association (AGA) guideline, evidence from randomized controlled trials, and the practical implications of integrating AI tools into clinical practice. Dr. Kahi is a Professor of Medicine at Indiana University School of Medicine, and he helped develop the AGA Living Clinical Practice Guideline on Computer-Aided Detection-Assiste...
  • Probiotics in GI Practice: Evidence, Guidelines, and Emerging Innovations
    Probiotics in GI Practice: Evidence, Guidelines, and Emerging Innovations 01.10.2025 13m
    Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Alexa Weingarden, MD PhD Probiotic use in gastroenterology remains a complex and evolving topic, shaped by variable evidence and growing patient demand. Dr. Peter Buch sits down with Dr. Alexa Weingarden to review current data, discuss distinctions between probiotic-related therapies, and explore the clinical utility of microbiome testing. Dr. Weingarden is an Assistant Professor of Gastroenterology, Hepatology, and Nutrition at the University of Minnesota Medical School.
  • Vomiting Syndromes: A Closer Look at CVS and CHS in Adult Patients
    Vomiting Syndromes: A Closer Look at CVS and CHS in Adult Patients 22.09.2025 12m
    Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David Levinthal, MD, PhD Cyclic vomiting syndrome (CVS) is often underdiagnosed in adults due to its episodic nature and symptom overlap with other conditions. Dr. David Levinthal joins Dr. Peter Buch to explore key diagnostic criteria, key differences between CVS and cannabinoid hyperemesis syndrome (CHS), and evidence-based treatment strategies. Dr. Levinthal is the Director of the UPMC Neurogastroenterology and Motility Center and an Associate Professor of Medicine at the University of Pittsburgh School of Medicine.
  • Diagnosing and Treating Immune Checkpoint Inhibitor Colitis Effectively
    Diagnosing and Treating Immune Checkpoint Inhibitor Colitis Effectively 19.09.2025 14m
    Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Yinghong Wang, MD, PhD, MS Immune checkpoint inhibitor (ICI) colitis comes with unique diagnostic and treatment challenges, which means that recognizing and managing it effectively is key to the best outcomes. Joining Dr. Peter Buch to share her insights on caring for patients with this complex condition is Dr. Yinghong Wang. Dr. Wang is a Professor in the Department of Gastroenterology, Hepatology, and Nutrition at MD Anderson Cancer Center in Houston, Texas, as well as Director of the Oncology-GI Toxicity Program, Director of Fecal Microbiota Tra...
  • Exploring Technological Advances in GI Training: Practical Insights for Clinicians
    Exploring Technological Advances in GI Training: Practical Insights for Clinicians 18.09.2025 12m
    Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Nabil Mansour, MD Artificial intelligence, simulation platforms, augmented reality, and other technological innovations are transforming our approach to GI training. In this expert-led discussion, Dr. Peter Buch sits down with Dr. Nabil Mansour to discuss how we can integrate cutting-edge tools into colonoscopy training while preserving core competencies. Dr. Mansour is an Associate Professor and the Director of the McNair General GI Clinic at Baylor College of Medicine in Houston.

Popular in

The podcast also appears in the podcast charts of these countries.